BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23990032)

  • 1. Clinical and molecular characteristics of HNSCC patients with brain metastases: a retrospective study.
    Bulut OC; Lindel K; Hauswald H; Brandt R; Klauschen F; Wolf J; Wolf T; Plinkert PK; Simon C; Weichert W; Stenzinger A
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1715-22. PubMed ID: 23990032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
    Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
    [No Abstract]   [Full Text] [Related]  

  • 4. Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV status.
    Fallai C; Perrone F; Licitra L; Pilotti S; Locati L; Bossi P; Orlandi E; Palazzi M; Olmi P
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1053-9. PubMed ID: 19577857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus in oropharyngeal squamous cell carcinoma: assessing virus presence in normal tissue and activity in cervical metastasis.
    Laborde RR; Janus JR; Olsen SM; Wang VW; Garcia JJ; Graham RP; Moore EJ; Olsen KD; Kasperbauer JL; Price DL; Berres M; Halling G; Smith DI
    Laryngoscope; 2012 Dec; 122(12):2707-11. PubMed ID: 22961429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of AKR1C1 and AKR1C3 expression in OPSCC with integrated HPV16 and HPV-negative tumors is an indicator of poor prognosis.
    Huebbers CU; Verhees F; Poluschkin L; Olthof NC; Kolligs J; Siefer OG; Henfling M; Ramaekers FCS; Preuss SF; Beutner D; Seehawer J; Drebber U; Korkmaz Y; Lam WL; Vucic EA; Kremer B; Klussmann JP; Speel EM
    Int J Cancer; 2019 May; 144(10):2465-2477. PubMed ID: 30367463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status.
    Kumar B; Brown NV; Swanson BJ; Schmitt AC; Old M; Ozer E; Agrawal A; Schuller DE; Teknos TN; Kumar P
    Oncotarget; 2016 Apr; 7(14):18665-77. PubMed ID: 26919244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Human Papillomavirus Integration in Brain Metastases from Oropharyngeal Tumors by Targeted Sequencing.
    McEllin B; Searle BC; DePledge L; Sun G; Cobbs C; Karimi M
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial stem cell marker LGR6 expression identifies a low-risk subgroup in human papillomavirus positive oropharyngeal squamous cell carcinoma.
    Jank BJ; Kadletz L; Dunkler D; Haas M; Schnoell J; Kenner L; Heiduschka G
    Oral Oncol; 2020 Jun; 105():104657. PubMed ID: 32244172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does HPV type affect outcome in oropharyngeal cancer?
    Nichols AC; Dhaliwal SS; Palma DA; Basmaji J; Chapeskie C; Dowthwaite S; Franklin JH; Fung K; Kwan K; Wehrli B; Howlett C; Siddiqui I; Salvadori MI; Winquist E; Ernst S; Kuruvilla S; Read N; Venkatesan V; Todorovic B; Hammond JA; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
    J Otolaryngol Head Neck Surg; 2013 Feb; 42(1):9. PubMed ID: 23663293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High E6 Gene Expression Predicts for Distant Metastasis and Poor Survival in Patients With HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
    Khwaja SS; Baker C; Haynes W; Spencer CR; Gay H; Thorstad W; Adkins DR; Nussenbaum B; Chernock RD; Lewis JS; Wang X
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1132-41. PubMed ID: 27209503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the total cfDNA and HPV16/18 detection in plasma samples of head and neck squamous cell carcinoma patients.
    Mazurek AM; Rutkowski T; Fiszer-Kierzkowska A; Małusecka E; Składowski K
    Oral Oncol; 2016 Mar; 54():36-41. PubMed ID: 26786940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.
    Horn D; Freudlsperger C; Holzinger D; Kunzmann K; Plinkert P; Dyckhoff G; Hoffmann J; Freier K; Hess J
    Head Neck; 2017 Dec; 39(12):2397-2405. PubMed ID: 28945300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of HPV prevalence in HNSCC patients with regard to regional and socioeconomic factors.
    Krupar R; Hartl M; Wirsching K; Dietmaier W; Strutz J; Hofstaedter F
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1737-45. PubMed ID: 24065189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Trosman SJ; Koyfman SA; Ward MC; Al-Khudari S; Nwizu T; Greskovich JF; Lamarre ED; Scharpf J; Khan MJ; Lorenz RR; Adelstein DJ; Burkey BB
    JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):457-62. PubMed ID: 25742025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral health and human papillomavirus-associated head and neck squamous cell carcinoma.
    Mazul AL; Taylor JM; Divaris K; Weissler MC; Brennan P; Anantharaman D; Abedi-Ardekani B; Olshan AF; Zevallos JP
    Cancer; 2017 Jan; 123(1):71-80. PubMed ID: 27571516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.